Cargando…

Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns

INTRODUCTION: The world is currently fighting a COVID-19 pandemic, perhaps the most disruptive infectious disease outbreak since the 1918 Spanish influenza. Governments have taken drastic measures to curb the spread of SARS-CoV-2, and the development of safe and efficacious vaccine candidates is bei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zellweger, Raphaël M., Wartel, T. Anh, Marks, Florian, Song, Manki, Kim, Jerome H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566857/ https://www.ncbi.nlm.nih.gov/pubmed/32838605 http://dx.doi.org/10.1080/14760584.2020.1800463

Ejemplares similares

Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism
por: Hoskisson, Paul A., et al.
Publicado: (2020)

Restless Legs Syndrome: Known Knowns and Known Unknowns
por: Antelmi, Elena, et al.
Publicado: (2022)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

SARS-CoV-2 variants of concern: the knowns and unknowns
por: Lessells, Richard J.
Publicado: (2021)

SARS-CoV-2 and the reproductive system: known and the unknown..!!
por: Sharma, Indu, et al.
Publicado: (2021)

SARS-CoV-2 and Zoonotic Preparedness: Unknown Knowns?
por: Irving, Aaron Trent, et al.
Publicado: (2021)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

Symptom tracking in endometriosis using digital technologies: Knowns, unknowns, and future prospects
por: Edgley, Katherine, et al.
Publicado: (2023)

The known knowns, known unknowns, and unknown unknowns of surveys and sleep
por: Shaker, Marcus, et al.
Publicado: (2022)

SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
por: Redondo, Natalia, et al.
Publicado: (2021)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
por: Chiok, Kim R., et al.
Publicado: (2023)

Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
por: Mouliou, Dimitra S., et al.
Publicado: (2022)

Sepsis-related stress response: known knowns, known unknowns, and unknown unknowns
por: Peng, Jinmin, et al.
Publicado: (2010)

Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
por: Sette, Alessandro, et al.
Publicado: (2020)

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
por: Barrière, Jérôme, et al.
Publicado: (2021)

Known unknowns and unknown unknowns
por: Burki, Talha
Publicado: (2018)

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
por: Lipsitch, Marc, et al.
Publicado: (2021)

GMMA-Based Vaccines: The Known and The Unknown
por: Mancini, Francesca, et al.
Publicado: (2021)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
por: Duarte, Nathan, et al.
Publicado: (2021)

Mechanisms of enhancer action: the known and the unknown
por: Panigrahi, Anil, et al.
Publicado: (2021)

Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies
por: Rouzine, Igor M., et al.
Publicado: (2023)

Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks
por: O’Shea, Jesse, et al.
Publicado: (2021)

Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021)

The known and the unknown
Publicado: (2010)

SARS-CoV-2 vaccine boosters: The time to act is now
por: Petersen, Maya, et al.
Publicado: (2021)

Evidence-based treatment during the SARS-CoV-2 pandemic: Identifying the knowns and unknowns of nebulization
por: Woods, J. Andrew
Publicado: (2021)

Mitophagy in yeast: known unknowns and unknown unknowns
por: Abeliovich, Hagai
Publicado: (2023)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in the immunocompromised host
por: Connolly, Caoilfhionn M., et al.
Publicado: (2022)

The Erosion of Public Trust and SARS-CoV-2 Vaccines— More Action Is Needed
por: Nahum, Ari, et al.
Publicado: (2021)

Should Health Care Institutions Mandate SARS-CoV-2 Vaccination for Staff?
por: Kates, Olivia S, et al.
Publicado: (2021)

Genetic characterization of SARS-CoV-2 & implications for epidemiology, diagnostics & vaccines in India
por: Abraham, Priya, et al.
Publicado: (2020)

Known and unknown matter
por: Ellis, Jonathan Richard
Publicado: (1994)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
por: Oronsky, Bryan, et al.
Publicado: (2021)

Modelling the SARS-CoV-2 vaccination campaign in Italy: the fundamental role of unreported cases
por: Traini, Marco Claudio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4o1b9ei7pidndnfo9jkm8olhmq